LIDDS AB has a total of 66 patent applications. It decreased the IP activity by 91.0%. Its first patent ever was published in 2003. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, medical technology and organic fine chemistry are FRIEDMAN MICHAEL, QLT USA INC and HORSTMANN MICHAEL.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | Republic of Korea | 6 | |
#4 | Australia | 5 | |
#5 | Canada | 5 | |
#6 | China | 5 | |
#7 | Israel | 5 | |
#8 | Mexico | 5 | |
#9 | South Africa | 5 | |
#10 | Russian Federation | 4 | |
#11 | Hong Kong | 2 | |
#12 | Hungary | 2 | |
#13 | Japan | 2 | |
#14 | United States | 2 | |
#15 | Brazil | 1 | |
#16 | Norway | 1 | |
#17 | Sweden | 1 | |
#18 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Organic fine chemistry | |
#4 | Materials and metallurgy | |
#5 | Chemical engineering |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Syringes | |
#4 | Rare-earth metal compounds | |
#5 | Specific use of cosmetics | |
#6 | Object sterilising | |
#7 | Diagnosis and surgery | |
#8 | Mixing |
# | Name | Total Patents |
---|---|---|
#1 | Axen Niklas | 37 |
#2 | Lennernaes Hans | 18 |
#3 | Hugosson Jonas | 14 |
#4 | Lennernas Hans | 13 |
#5 | Gruden Stefan | 12 |
#6 | Malmsten Lars Ake | 11 |
#7 | Axén Niklas | 10 |
#8 | Carlsson Anders | 8 |
#9 | Eketorp Gunilla | 8 |
#10 | Pilbrant Ake G | 8 |
Publication | Filing date | Title |
---|---|---|
WO2019170912A1 | Bioresorbable controlled-release compositions with sting modulating molecules | |
US2019119122A1 | Method for producing calcium sulphate hemihydrate with unique properties | |
RU2536415C2 | Application of carboxymethylcellulose for control of pressability and hardening time of compositions, containing one or more ceramic materials | |
WO2010034462A1 | Injector device | |
AU2007224651A1 | Bioresorbable controlled-release composition | |
CN101160116A | Method for treating prostate diseases based on local delivery of active substances | |
EP1680089A1 | Composition comprising biodegradable hydrating ceramics for controlled drug delivery |